World

Zelensky meets Rutte on Ukrainian, European security

Apr 16, 2025

Kyiv [Ukraine], April 16: Ukrainian President Volodymyr Zelensky met on Tuesday with visiting North Atlantic Treaty Organization (NATO) Secretary General Mark Rutte to discuss Ukrainian and European security, the presidential press service reported.
At the meeting in Ukraine's southern city of Odesa, Zelensky and Rutte discussed various formats of cooperation between Ukraine and NATO member states, including in Ramstein format.
The talks also focused on Ukraine's relations with the U.S. and Washington's efforts in negotiations with Russia.
The report said Zelensky accused Russia of "ignoring the U.S. proposal for a full ceasefire" and continuing its strikes on Ukraine.
Emphasizing the need to strengthen Ukraine's air defense, Zelensky voiced hope for the implementation of air defense-related agreements with partners in Europe and the U.S.
He also noted that the UK, France, and other NATO countries are actively laying the foundation for a security contingent in Ukraine.
For his part, Rutte reaffirmed that the alliance will continue to stand with Ukraine.
According to him, in the first three months of this year, NATO member states pledged over 20 billion euros (about 22.5 billion U.S. dollars) in security assistance to Ukraine for 2025.
Source: Xinhua News Agency

More news

Indian Research on Young-Onset Parkinson's Disease Receives Recognition at Global GP2 Conference

Bengaluru (Karnataka) [India], November 13: A study conducted by the Parkinson’s Research Alliance of India (PRAI) on the genetic basis of early-onset Parkinson’s disease (PD) in Indian patients has received international recognition as it won the “Best Poster” award at the Global Parkinson’s Genetics Program (GP2) Annual Conference held in Seoul, South Korea, in October 2026. The Global Parkinson’s Genetics Program (GP2), an initiative under Aligning Science Across Parkinson’s (ASAP), brings together researchers worldwide to advance the understanding of Parkinson’s disease genetics with a focus on populations historically underrepresented in research, and support globally relevant discoveries that can inform future therapeutic strategies.

Nov 13, 2026